Does RESLIZUMAB Cause Nasopharyngitis? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Nasopharyngitis have been filed in association with RESLIZUMAB (CINQAIR). This represents 1.3% of all adverse event reports for RESLIZUMAB.
8
Reports of Nasopharyngitis with RESLIZUMAB
1.3%
of all RESLIZUMAB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Nasopharyngitis From RESLIZUMAB?
Of the 8 reports, 1 (12.5%) required hospitalization.
Is Nasopharyngitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RESLIZUMAB. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does RESLIZUMAB Cause?
Dyspnoea (86)
Asthma (82)
Drug ineffective (80)
Incorrect dose administered (63)
Hypertension (47)
Headache (41)
Wheezing (40)
Cough (36)
Oropharyngeal pain (31)
Fatigue (29)
What Other Drugs Cause Nasopharyngitis?
ADALIMUMAB (13,753)
ETANERCEPT (12,421)
METHOTREXATE (8,046)
TOFACITINIB (7,781)
SECUKINUMAB (7,022)
TOCILIZUMAB (6,664)
RITUXIMAB (6,321)
ABATACEPT (6,143)
INFLIXIMAB (5,353)
CERTOLIZUMAB PEGOL (5,295)
Which RESLIZUMAB Alternatives Have Lower Nasopharyngitis Risk?
RESLIZUMAB vs RESMETIROM
RESLIZUMAB vs RESTASIS
RESLIZUMAB vs RETINOL
RESLIZUMAB vs REVATIO
RESLIZUMAB vs REVEFENACIN